CRO BioClinica said it inked two long-term deals with major drugmakers totaling $30 million, touting its eClinical technology as driving sponsor interest. Without disclosing its clients, BioClinica said each deal was the product of an earlier collaboration in which the company's platform of software-based offerings won it a follow-on contract. After going through two mergers in as many years, the Newtown, PA, CRO is working to diversify its technology by expanding into imaging and patient recruitment. More